Insulet
PODD
175 hedge funds and large institutions have $2.45B invested in Insulet in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 37 closing their positions.
192% more call options, than puts
Call options by funds: $4.41M | Put options by funds: $1.51M
2% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 64
6% less funds holding
Funds holding: 186 → 175 (-11)
16% less capital invested
Capital invested by funds: $2.91B → $2.45B (-$458M)
30% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 37
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$73.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.1M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$17.4M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$16.1M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.1M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$23.2M |
| 3 |
Millennium Management
New York
|
-$21.7M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$21.7M |
| 5 |
O
OppenheimerFunds
New York
|
-$18.2M |
PODD Hedge Fund Activity: Q2 2014 in Review
175 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2014, worth a combined $2.45B — down 16% from $2.91B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of PODD and 26 opened new positions — a net loss of 11 holders — while 64 trimmed existing stakes and 65 added.
The largest buyer was AllianceBernstein, adding an estimated $73.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $28.1M.
- 175 institutional investors held Insulet (PODD) as of Q2 2014, down from 186 in Q1 2014.
- Funds reported $2.45B of Insulet stock for Q2 2014, down 16% quarter-over-quarter.
- 26 funds opened new Insulet positions in Q2 2014 and 37 closed out, a net change of -11 holders.
- The largest Insulet buyer in Q2 2014 was AllianceBernstein, an estimated $73.4M added.
- The largest Insulet seller in Q2 2014 was T. Rowe Price Associates, an estimated $28.1M sold.
Based on aggregated 13F filings for Q2 2014.